United States In Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers United States In Vitro Diagnostics Market Companies and is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Haematology, and Other Test Types), Product (Instruments, Reagents, and Other Products), Usability (Disposable IVD and Reusable IVD), Application (Infectious Diseases, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users). The Market Size and Forecast are Provided in Terms of Value (In USD Million) for the Above Segments.

United States In Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

United States In Vitro Diagnostics Industry Overview

The In Vitro Diagnostic market is moderately competitive and consists of several major players. Companies, like Abbott Laboratories, Becton, Dickinson and Company, and Danaher Corporation, are adopting strategic actions, mergers, acquisitions, and continued technological advancements, in order to retain their market share in the future. The companies are focusing on increasing technological advancements, in order to address the customer needs, like fully automated systems, that provide fast and accurate results.

United States In Vitro Diagnostics Market Leaders

  1. Danaher Corporation

  2. bioMerieux SA

  3. F Hoffmann-La Roche AG

  4. Becton, Dickinson and Company

  5. Abbott Laboratories

  6. *Disclaimer: Major Players sorted in no particular order
Picture3.png

United States In Vitro Diagnostics Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?